中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
4期
646-650
,共5页
张青%丁成赟%王潇慧%刘金民
張青%丁成赟%王瀟慧%劉金民
장청%정성빈%왕소혜%류금민
癫痫%耐药
癲癇%耐藥
전간%내약
Epilepsy%Drug-resistance
癫痫是一种慢性反复发作性疾病,经正规治疗仍有20%~30%患者对抗癫痫药物耐药而发展成为难治性癫痫,进而求助于手术、生物疗法,但这些方法价格昂贵、疗效不确定。明确癫痫的耐药机制,发展新型的神经治疗措施是大势所趋。现就癫痫的耐药机制作一综述。
癲癇是一種慢性反複髮作性疾病,經正規治療仍有20%~30%患者對抗癲癇藥物耐藥而髮展成為難治性癲癇,進而求助于手術、生物療法,但這些方法價格昂貴、療效不確定。明確癲癇的耐藥機製,髮展新型的神經治療措施是大勢所趨。現就癲癇的耐藥機製作一綜述。
전간시일충만성반복발작성질병,경정규치료잉유20%~30%환자대항전간약물내약이발전성위난치성전간,진이구조우수술、생물요법,단저사방법개격앙귀、료효불학정。명학전간적내약궤제,발전신형적신경치료조시시대세소추。현취전간적내약궤제작일종술。
Epilepsy is a chronic, recurrent paroxysmal disease. About 20%-30% of epilepsy patients are resistant to anti-epilepsy drugs after rational therapy. Finding another way to treat this disease, such as surgery and physiotherapy is expensive and the efficacy is unknown. It’s necessary to develop new neurological strategies according to the mechanism of drug-resistance in epilepsy, which was reviewed in this paper.